LOGIN
Pamidronate reduces femoral calcar bone loss, bone turnover after THA
August 2013
Pamidronate reduces femoral calcar bone loss, bone turnover after THA
Study Type:Therapy
OE Level Evidence:2
Journal Level of Evidence:N/A
Effect of pamidronate on bone turnover and implant migration after total hip arthroplasty: A randomized trial
J Orthop Res. 2005 Jan;23(1):1-8.Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Synopsis
42 patients who have undergone total hip arthroplasty were randomized to receive pamidronate or a placebo to determine the effect of pamidronate on periprosthetic bone turnover and pelvic implant migration. The results of the study indicated that pamidronate reduced femoral calcar bone loss and bone turnover, but did not influence cup migration.
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Learn about our AI Driven
High Impact Search Feature
Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.
Continue
Join the Conversation
Please Login or Join to leave comments.